Pharmacist announces application for authorization for drug for covid-19

Pharmaceuticals Merck announced today that it will ask the US regulator to authorize the emergency use of a drug to treat people infected with SARS-CoV-2, following the results of trials with patients with covid-19.

According to the company, which also intends to proceed with the authorization request to other regulatory entities, the phase three tests with this oral antiviral – molnupiravir – halved hospitalizations and deaths in infected people with mild symptoms.

If approved, the drug will be the first pill to treat covid-19, since, so far, all authorized therapies require intravenous intervention in a hospital setting.

Merck and Ridgeback Biotherapeutics added that the first results showed that in the group of patients who received molnupiravir for five days after symptoms, there was a rate of hospitalization and death of about d. and half compared to the group given a placebo.

The study followed 775 adults with covid-19 with mild to moderate symptoms and who were considered at higher risk for severe disease due to health problems such as obesity, diabetes or heart disease.

Among patients taking molnupiravir, 7.3% were hospitalized or died at the end of 30 days, compared with 14.1 % of those who took the placebo, says the Associated Press agency.

An independent group of experts who monitored the study recommended its early interruption due to the results obtained, a procedure that happens when the data demonstrate that a treatment works and that, therefore, there is no need for further tests before requesting authorization.

The responsible of the laboratories also said that they intend to send the data to the North regulator. American (FDA) in the coming days, which may make a decision within a period of time. s weeks.

“It exceeded what I thought the drug might be able to do in this clinical trial,” said Dean Li, vice president of Merck Research Laboratories, who says a reduction in 50% of hospitalizations and deaths “is a substantial clinical impact.”

The Merck tablet, twice daily for five days, interferes with the coronavirus’s ability to copy its genetic code and to reproduce.

The US government has already committed to purchase 1.7 million doses of the drug, if authorized by the FDA, and Merck has said that it can produce 10 million doses up to the end of the year.

Note: This article have been indexed to our website. We do not claim ownership or copyright of any of the content above. To see the article at the original source Click Here

Related Posts
Kane makes Bundesliga history with an impressive hat-trick for Bayern Munich thumbnail

Kane makes Bundesliga history with an impressive hat-trick for Bayern Munich

Harry Kane has achieved a historic milestone by becoming the fastest starter in the German Bundesliga. The English captain delivered an extraordinary performance for Bayern Munich against Bochum on Saturday, securing a remarkable hat-trick along with two assists. His outstanding display played a pivotal role in Bayern's 7-0 victory. Kane wasted no time, finding the
Read More
Question about the shutdown of the Greek Euronews thumbnail

Question about the shutdown of the Greek Euronews

MEDIA 03.10.2021, 16:44 efsyn.gr Κατεπείγουσα ερώτηση προς την Ευρωπαϊκή Επιτροπή, «για το σχέδιο διακοπής λειτουργίας της ελληνικής υπηρεσίας του Euronews μέχρι το τέλος του έτους», κατέθεσαν οι ευρωβουλευτές της Νέας Δημοκρατίας με πρωτοβουλία του αντιπροέδρου της ΚΟ του ΕΛΚ στο Ευρωπαϊκό Κοινοβούλιο, Βαγγέλη Μεϊμαράκη.Στην ερώτηση, οι ευρωβουλευτές της Ν.Δ. υπογραμμίζουν την αδιάκοπη και έγκυρη ενημέρωση…
Read More
Monthly Horoscope: Capricorn, June 2023 thumbnail

Monthly Horoscope: Capricorn, June 2023

The sun in Gemini illuminates a busy sector of your chart, inspiring you to tackle your to-do list, organize your workspace, and rearrange your schedule to make it as productive as possible! You could be starting a new gig or making great strides in a project. You might be ending old habits or starting new
Read More
LIVE-TV ONSDAG 19.00: Boltic-Trollhättan thumbnail

LIVE-TV ONSDAG 19.00: Boltic-Trollhättan

På onsdag tar Boltic emot Trollhättan på... Lokaljournalistik när och var du vill 8 veckor för 8 kr Med plus får du tillgång till alla artiklar på sajten och i vår nyhetsapp för 8 kr de första 8 veckorna, därefter ord. Pris 129 kr/mån utan bindningstid. Du får även tillgång till digitala nyheter på 16…
Read More
Index Of News
Total
0
Share